Literature DB >> 18201269

Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.

Shingo Mitomo1, Chihaya Maesawa, Satoshi Ogasawara, Takeshi Iwaya, Masahiko Shibazaki, Akiko Yashima-Abo, Koji Kotani, Hiroki Oikawa, Eiich Sakurai, Naoko Izutsu, Kuniyuki Kato, Hideaki Komatsu, Kenichro Ikeda, Go Wakabayashi, Tomoyuki Masuda.   

Abstract

Alterations of several microRNA (miRNA) have been linked to cancer development and its biology. To search for unique miRNA that might play a role in the development of anaplastic thyroid carcinoma (ATC), we examined the expression of multiple miRNA and their functional effects on target genes in human thyroid carcinoma cell lines. We quantitatively evaluated the expression of multiple miRNA in 10 ATC and five papillary thyroid carcinoma (PTC) cell lines, as well as primary tumors from 11 thyroid carcinoma patients (three ATC and eight PTC), using the stem-loop-mediated reverse transcription real-time polymerase chain reaction method. We also examined the target gene specificity of unique miRNA that showed differences in expression between ATC and PTC cell lines. One miRNA, miR-138, was significantly downregulated in ATC cell lines in comparison with PTC (P < 0.01). Eleven miRNA (including miR-138) potentially targeting the human telomerase reverse transcriptase (hTERT) gene were totally downregulated in both ATC and PTC cell lines in comparison with normal thyroid tissues. A tendency for an inverse correlation between miR-138 and hTERT protein expression was observed in the thyroid cancer cell lines, although this failed to reach significance (r = -0.392, P = 0.148). We demonstrated that overexpression of miR-138 induced a reduction in hTERT protein expression, and confirmed target specificity between miR-138 and the hTERT 3'-untranslated region by luciferase reporter assay. These results suggest that loss of miR-138 expression may partially contribute to the gain of hTERT protein expression in ATC, and that further multiple miRNA targeting hTERT mRNA might be involved in the development of thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18201269     DOI: 10.1111/j.1349-7006.2007.00666.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  112 in total

1.  miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.

Authors:  Mian Ling Chen; Liu Sen Liang; Xiao Kang Wang
Journal:  Clin Exp Metastasis       Date:  2012-03-10       Impact factor: 5.150

2.  p63-microRNA feedback in keratinocyte senescence.

Authors:  Pia Rivetti di Val Cervo; Anna Maria Lena; Milena Nicoloso; Simona Rossi; Mara Mancini; Huiqing Zhou; Gaelle Saintigny; Elena Dellambra; Teresa Odorisio; Christian Mahé; George Adrian Calin; Eleonora Candi; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-06       Impact factor: 11.205

3.  Identification of microRNAs associated with hyperthermia-induced cellular stress response.

Authors:  Gerald J Wilmink; Caleb L Roth; Bennett L Ibey; Norma Ketchum; Joshua Bernhard; Cesario Z Cerna; William P Roach
Journal:  Cell Stress Chaperones       Date:  2010-03-30       Impact factor: 3.667

4.  Identification of microRNAs that mediate thyroid cell growth induced by TSH.

Authors:  Takeshi Akama; Mariko Sue; Akira Kawashima; Huhehasi Wu; Kazunari Tanigawa; Sayuri Suzuki; Moyuru Hayashi; Aya Yoshihara; Yuko Ishido; Norihisa Ishii; Koichi Suzuki
Journal:  Mol Endocrinol       Date:  2012-02-02

5.  Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma.

Authors:  Lu Jiang; Yang Dai; Xiqiang Liu; Cheng Wang; Anxun Wang; Zujian Chen; Caroline E Heidbreder; Antonia Kolokythas; Xiaofeng Zhou
Journal:  Hum Genet       Date:  2010-11-16       Impact factor: 4.132

6.  MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.

Authors:  Menno R Vriens; Julie Weng; Insoo Suh; Nhung Huynh; Marlon A Guerrero; Wen T Shen; Quan-Yang Duh; Orlo H Clark; Electron Kebebew
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

Review 7.  Deregulation of microRNA expression in thyroid neoplasias.

Authors:  Pierlorenzo Pallante; Sabrina Battista; Giovanna Maria Pierantoni; Alfredo Fusco
Journal:  Nat Rev Endocrinol       Date:  2013-11-19       Impact factor: 43.330

8.  Role of miR-138 in the regulation of larynx carcinoma cell metastases.

Authors:  Shang Gao; Jie Wang; Jin Xie; Tianzhen Zhang; Pin Dong
Journal:  Tumour Biol       Date:  2015-10-24

Review 9.  miR-221/222: promising biomarkers for breast cancer.

Authors:  Wei-Xian Chen; Qing Hu; Man-Tang Qiu; Shan-Liang Zhong; Jin-Jin Xu; Jin-Hai Tang; Jian-Hua Zhao
Journal:  Tumour Biol       Date:  2013-03-27

Review 10.  Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.

Authors:  Robert C Smallridge; Laura A Marlow; John A Copland
Journal:  Endocr Relat Cancer       Date:  2008-11-05       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.